Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia

G. Reda, M. Riva, B. Fattizzo, R. Cassin, D. Giannarelli, M. Pennisi, A. Freyrie, R. Cairoli, A. Molteni, A. Cortelezzi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)202-208
Number of pages7
JournalSeminars in Hematology
Volume55
Issue number4
DOIs
Publication statusPublished - 2018

Keywords

  • azacitidine, acute myeloid leukemia
  • adult
  • age
  • aged
  • blood toxicity
  • cancer prognosis
  • cancer risk
  • chronic myelomonocytic leukemia
  • controlled study
  • cytogenetics
  • drug safety
  • febrile neutropenia
  • female
  • high risk patient
  • human
  • infection
  • infection rate
  • intermediate risk patient
  • low risk patient
  • major clinical study
  • male
  • median survival time
  • multiple cycle treatment
  • myelodysplastic syndrome
  • myelofibrosis
  • overall survival
  • priority journal
  • retrospective study
  • Review
  • survival prediction
  • thrombocytopenia

Cite this

@article{d84e9d72511e4fde92b042b068fcf64d,
title = "Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia",
keywords = "azacitidine, acute myeloid leukemia, adult, age, aged, blood toxicity, cancer prognosis, cancer risk, chronic myelomonocytic leukemia, controlled study, cytogenetics, drug safety, febrile neutropenia, female, high risk patient, human, infection, infection rate, intermediate risk patient, low risk patient, major clinical study, male, median survival time, multiple cycle treatment, myelodysplastic syndrome, myelofibrosis, overall survival, priority journal, retrospective study, Review, survival prediction, thrombocytopenia",
author = "G. Reda and M. Riva and B. Fattizzo and R. Cassin and D. Giannarelli and M. Pennisi and A. Freyrie and R. Cairoli and A. Molteni and A. Cortelezzi",
note = "cited By 0",
year = "2018",
doi = "10.1053/j.seminhematol.2018.02.005",
language = "English",
volume = "55",
pages = "202--208",
journal = "Seminars in Hematology",
issn = "0037-1963",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia

AU - Reda, G.

AU - Riva, M.

AU - Fattizzo, B.

AU - Cassin, R.

AU - Giannarelli, D.

AU - Pennisi, M.

AU - Freyrie, A.

AU - Cairoli, R.

AU - Molteni, A.

AU - Cortelezzi, A.

N1 - cited By 0

PY - 2018

Y1 - 2018

KW - azacitidine, acute myeloid leukemia

KW - adult

KW - age

KW - aged

KW - blood toxicity

KW - cancer prognosis

KW - cancer risk

KW - chronic myelomonocytic leukemia

KW - controlled study

KW - cytogenetics

KW - drug safety

KW - febrile neutropenia

KW - female

KW - high risk patient

KW - human

KW - infection

KW - infection rate

KW - intermediate risk patient

KW - low risk patient

KW - major clinical study

KW - male

KW - median survival time

KW - multiple cycle treatment

KW - myelodysplastic syndrome

KW - myelofibrosis

KW - overall survival

KW - priority journal

KW - retrospective study

KW - Review

KW - survival prediction

KW - thrombocytopenia

U2 - 10.1053/j.seminhematol.2018.02.005

DO - 10.1053/j.seminhematol.2018.02.005

M3 - Article

VL - 55

SP - 202

EP - 208

JO - Seminars in Hematology

JF - Seminars in Hematology

SN - 0037-1963

IS - 4

ER -